The VIGILANT Study
Do you have moderate to severe COPD? You may be eligible for a research study to test an investigational drug called depemokimab compared to placebo as an add-on treatment for moderate to severe COPD, given as an injection. Study participation is expected to last 1-3 years during which there will be, on average, about one visit per month. Compensation is provided.